Skip to content

Clinical trials

Completed Phase 3 Opioid-Related Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Opioid-Related Disorders Phase: Phase 3 Status: Completed Clear all

66 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20014
20021
20032
20053
20065
20074
20082
20094
20105
20112
20122
20134
20142
20157
20163
20174
20202
20212
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed66

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of California, Los Angeles6
Yale University6
Butler Hospital5
Titan Pharmaceuticals5
Alkermes, Inc.4
New York State Psychiatric Institute4
Indivior Inc.3
University of British Columbia3
University of Pennsylvania3
Braeburn Pharmaceuticals2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Opioid-Related Disorders66
Substance-Related Disorders11
Heroin Dependence7
Substance Withdrawal Syndrome3
Chronic Pain2
Cocaine-Related Disorders2
Morphine Dependence2
Neonatal Abstinence Syndrome2
Agnosia1
Alcoholism1

Trials

Showing 1 to 25 of 66. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.